GlaxoSmithKline secured approval from the FDA to supply its influenza vaccine, Fluarix Quadrivalent, to CDC distribution centers and health care providers in the U.S. Fluarix was approved by the FDA last year to protect adults and children 3 and older against four strains of flu. The CDC ordered more than 4 million doses of the vaccine.

Related Summaries